EGFR-Family Expression and Implications for Targeted Radionuclide Therapy-Reference-Cited by-同舟云学术

EGFR-Family Expression and Implications for Targeted Radionuclide Therapy

Published:2008 Issue: Volume: Page:25-58
ISSN:
Container-title:Targeted Radionuclide Tumor Therapy
language:
Short-container-title:

Author:

Carlsson Jörgen

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-1-4020-8696-0_3.pdf

Reference188 articles.

1. McGill MA, McGlade CJ (2004) Cellular signaling. In: The Basic Science of Oncology (editors: Tannock IF, Hill RP, Bristow RC and Harrington L). McGraw-Hill Medical Publishing Division, New York (ISBN-13: 978-0-07-138774-3), Chapter 8, pp142-166

2. Pecorino L (2005) Molecular Biology of Cancer. Mechanisms, Targets and Therapeutics. Oxford University Press, Oxford (ISBN 0-19-926472-4)

3. Carlsson J, Forssell AE, Hietala SO, Stigbrand T, Tennvall J (2003) Tumour therapy with radionuclides: assessment of progress and problems. Radiother Oncol 66: 107-17

4. Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23(9): 1147-57. Review

5. DeNardo SJ, DeNardo GL (2006) Targeted radionuclide therapy for solid tumors: an overview. Int J Radiat Oncol Biol Phys 66(Suppl 2): S89-95. Review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule;Scientific Reports;2017-07-20

2. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules;Molecular Pharmaceutics;2016-04-06

3. EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides;Radiology and Oncology;2015-03-01

4. Synthesis and stability test of radiogadolinium(III)-DOTA-PAMAM G3.0-trastuzumab as SPECT-MRI molecular imaging agent for diagnosis of HER-2 positive breast cancer;Journal of Radiation Research and Applied Sciences;2015-01

5. Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68 Ga-Compared to 111 In-Labeled Conjugates;Molecular Imaging;2014-12